Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 25.42108.7630.47-21.08-35.31

What is the latest Core EBITDA Growth ratio of TTK HEALTHCARE ?

The latest Core EBITDA Growth ratio of TTK HEALTHCARE is 25.42 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202425.42
Mar2023108.76
Mar202230.47
Mar2021-21.08
Mar2020-35.31

How is Core EBITDA Growth of TTK HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2024 25.42
-76.63
Mar2023 108.76
256.94
Mar2022 30.47
Positive
Mar2021 -21.08
Negative
Mar2020 -35.31 -

Other Financial Ratios of TTK HEALTHCARE


Compare Core EBITDA Growth ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,882.4 Cr 0.2% -6.6% -8.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,400.0 Cr 2% -0.9% 31.9% Stock Analytics
DIVIS LABORATORIES ₹154,622.0 Cr -1.6% -0.4% 57.3% Stock Analytics
CIPLA ₹116,240.0 Cr -0.3% -2.5% 7.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,166.0 Cr -0.5% -3.3% 14% Stock Analytics
ZYDUS LIFESCIENCES ₹98,495.2 Cr -1% 0.6% 39.1% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

0.2%

-6.6%

-8.8%

SENSEX

-0.4%

-2.1%

6.9%


You may also like the below Video Courses